Boundless Bio Inc (BOLD)
3.26
-0.32
(-8.94%)
USD |
NASDAQ |
Nov 14, 16:00
3.26
0.00 (0.00%)
After-Hours: 18:07
Boundless Bio Enterprise Value: -99.62M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | -99.62M |
| November 12, 2024 | -96.95M |
| November 11, 2024 | -99.62M |
| November 08, 2024 | -101.40M |
| November 07, 2024 | -105.41M |
| November 06, 2024 | -108.74M |
| November 05, 2024 | -112.75M |
| November 04, 2024 | -114.53M |
| November 01, 2024 | -112.97M |
| October 31, 2024 | -114.31M |
| October 30, 2024 | -114.31M |
| October 29, 2024 | -109.63M |
| October 28, 2024 | -112.53M |
| October 25, 2024 | -114.31M |
| October 24, 2024 | -112.75M |
| October 23, 2024 | -112.08M |
| October 22, 2024 | -111.86M |
| October 21, 2024 | -111.86M |
| October 18, 2024 | -111.41M |
| October 17, 2024 | -111.86M |
| October 16, 2024 | -111.64M |
| October 15, 2024 | -111.64M |
| October 14, 2024 | -112.08M |
| October 11, 2024 | -112.08M |
| October 10, 2024 | -114.08M |
| Date | Value |
|---|---|
| October 09, 2024 | -114.75M |
| October 08, 2024 | -111.41M |
| October 07, 2024 | -108.52M |
| October 04, 2024 | -108.52M |
| October 03, 2024 | -109.63M |
| October 02, 2024 | -109.86M |
| October 01, 2024 | -106.74M |
| September 30, 2024 | -102.07M |
| September 27, 2024 | -103.85M |
| September 26, 2024 | -100.95M |
| September 25, 2024 | -102.51M |
| September 24, 2024 | -103.85M |
| September 23, 2024 | -96.95M |
| September 20, 2024 | -81.37M |
| September 19, 2024 | -84.26M |
| September 18, 2024 | -102.07M |
| September 17, 2024 | -103.18M |
| September 16, 2024 | -95.39M |
| September 13, 2024 | -99.40M |
| September 12, 2024 | -107.85M |
| September 11, 2024 | -110.97M |
| September 10, 2024 | -107.41M |
| September 09, 2024 | -108.08M |
| September 06, 2024 | -109.63M |
| September 05, 2024 | -108.08M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-115.20M
Minimum
Aug 12 2024
198.02M
Maximum
Apr 02 2024
-17.81M
Average
-93.17M
Median
Enterprise Value Benchmarks
| CEL-SCI Corp | 38.36M |
| AIM ImmunoTech Inc | 7.900M |
| IGC Pharma Inc | 26.09M |
| NovaBay Pharmaceuticals Inc | 3.432M |
| Protalix BioTherapeutics Inc | 66.58M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.98M |
| Total Expenses (Quarterly) | 19.39M |
| EPS Diluted (Quarterly) | -0.77 |
| Earnings Yield | -434.9% |